KOLTEPATIL.BO(KOLTEPATIL.BO)
KOLTEPATIL.BO
No analyst ratings available
No analyst price targets available for KOLTEPATIL.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $14.86B | $18.87B |
| Low | $12.94B | $13.20B |
| High | $16.57B | $26.06B |
| EBITDA Avg | $1.16B | $1.47B |
| Low | $1.01B | $1.03B |
| High | $1.29B | $2.03B |
| EBIT Avg | $986M | $1.25B |
| Low | $858M | $876M |
| High | $1.10B | $1.73B |
| Net Income Avg | $1.04B | $2.17B |
| Low | $1.00B | $1.12B |
| High | $1.17B | $2.47B |
| EPS Avg | $12.65 | $22.30 |
| Low | $11.70 | $13.07 |
| High | $13.60 | $28.79 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 2 |
| Metric | Q2 2026 |
|---|---|
| Revenue Avg | $2.48B |
| Low | $2.48B |
| High | $2.48B |
| EBITDA Avg | $193M |
| Low | $193M |
| High | $193M |
| EBIT Avg | $165M |
| Low | $165M |
| High | $165M |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |